Q&A With Emmanuel Labourier From BMDx Consulting: Taking a Closer Look at Molecular Diagnostic Test for Thyroid Cancer

Video

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and exclusivity to help patients get a better idea of their condition.

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and sensitivity to help patients get a better idea of their condition.

Emmanuel Labourier, PhD, discussed the importance of this test during the AACE's 24th Annual Scientific and Clinical Congress in Nashville. Labourier said the new test reduces the need for surgery "two or three fold."

Recent Videos
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.